Literature DB >> 11226701

Evidence that regenerating optic axons maintain long-term growth in the lizard Ctenophorus ornatus: growth-associated protein-43 and gefiltin expression.

J Rodger1, C A Bartlett, A M Harman, C Thomas, L D Beazley, S A Dunlop.   

Abstract

In the lizard, Ctenophorus ornatus, the optic nerve regenerates but animals remain blind via the experimental eye, presumably as a result of axons failing to consolidate a retinotopic map in the optic tectum. Here we have examined immunohistochemically the expression of the growth-associated protein GAP-43 and the low-molecular-weight intermediate filament protein gefiltin, up to one year after optic nerve crush. Both proteins were found to be permanently up-regulated, suggesting that regenerating axons are held in a permanent state of re-growth. We speculate that, in the lizard, the continued expression of GAP-43 and the failure to switch from the expression of low- to high-molecular-weight intermediate filament proteins are associated with the inability to consolidate a retinotopic projection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226701     DOI: 10.1016/s0306-4522(00)00506-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  3 in total

1.  Developmental and regional patterns of GAP-43 immunoreactivity in a metamorphosing brain.

Authors:  Andrea Megela Simmons; Leslie H Tanyu; Seth S Horowitz; Judith A Chapman; Rebecca A Brown
Journal:  Brain Behav Evol       Date:  2008-04-21       Impact factor: 1.808

2.  Regrowth of transected retinal ganglion cell axons despite persistent astrogliosis in the lizard (Gallotia galloti).

Authors:  María del Mar Romero-Alemán; Maximina Monzón-Mayor; Elena Santos; Carmen M Yanes
Journal:  J Anat       Date:  2013-05-09       Impact factor: 2.610

3.  Heterogeneous nuclear ribonucleoprotein K, an RNA-binding protein, is required for optic axon regeneration in Xenopus laevis.

Authors:  Yuanyuan Liu; Hurong Yu; Sarah K Deaton; Ben G Szaro
Journal:  J Neurosci       Date:  2012-03-07       Impact factor: 6.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.